Ginkgo Bioworks: William H. Gates III reports 6.2% stake
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Ginkgo Bioworks Holdings, Inc. (DNA) ownership amendment lists Cascade Investment, L.L.C. and William H. Gates III as beneficial owners of 3,322,584 Class A shares, representing 6.2% of the class. The shares are held by Cascade and may also be deemed beneficially owned by Gates as Cascade’s sole member, so the two entries describe the same block. The percentage is based on 53,943,682 shares outstanding as of October 30, 2026.
Key Figures
Key Terms
beneficially owned regulatory
Sole Voting Power regulatory
Sole Dispositive Power regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.